ATP6V1A
Basic information
Region (hg38): 3:113746770-113812056
Previous symbols: [ "VPP2", "ATP6A1", "ATP6V1A1" ]
Links
Phenotypes
GenCC
Source:
- epileptic encephalopathy, infantile or early childhood, 3 (Definitive), mode of inheritance: AD
- autosomal recessive cutis laxa type 2D (Moderate), mode of inheritance: AR
- autosomal recessive cutis laxa type 2D (Strong), mode of inheritance: AR
- autosomal recessive cutis laxa type 2D (Limited), mode of inheritance: AR
- epileptic encephalopathy, infantile or early childhood, 3 (Moderate), mode of inheritance: AD
- autosomal recessive cutis laxa type 2, classic type (Supportive), mode of inheritance: AR
- undetermined early-onset epileptic encephalopathy (Supportive), mode of inheritance: AD
- autosomal recessive cutis laxa type 2D (Strong), mode of inheritance: AR
- epileptic encephalopathy, infantile or early childhood, 3 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Cutis laxa, autosomal recessive, type IID | AR | Cardiovascular | The condition can include early-onset cardiomyopathy, and awareness may allow early diagnosis and management | Cardiovascular; Craniofacial; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic | 24459010; 28065471; 29668857 |
ClinVar
This is a list of variants' phenotypes submitted to
- not provided (2 variants)
- Epileptic encephalopathy, infantile or early childhood, 3 (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the ATP6V1A gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 58 | 64 | ||||
missense | 116 | 128 | ||||
nonsense | 2 | |||||
start loss | 0 | |||||
frameshift | 6 | |||||
inframe indel | 1 | |||||
splice donor/acceptor (+/-2bp) | 1 | |||||
splice region | 5 | 10 | 1 | 16 | ||
non coding | 39 | 16 | 55 | |||
Total | 3 | 8 | 129 | 97 | 20 |
Variants in ATP6V1A
This is a list of pathogenic ClinVar variants found in the ATP6V1A region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
3-113778539-C-G | Benign (May 10, 2021) | |||
3-113778660-A-G | Benign (May 10, 2021) | |||
3-113778782-T-G | Uncertain significance (Sep 04, 2023) | |||
3-113778783-C-T | Likely benign (Dec 19, 2023) | |||
3-113778784-G-A | Uncertain significance (May 16, 2022) | |||
3-113778784-G-T | Epileptic encephalopathy, infantile or early childhood, 3 | Uncertain significance (Jan 25, 2023) | ||
3-113778801-C-T | Likely benign (Aug 01, 2020) | |||
3-113778809-G-C | Uncertain significance (Mar 31, 2023) | |||
3-113778818-A-G | Inborn genetic diseases | Uncertain significance (May 18, 2023) | ||
3-113778822-G-A | Likely benign (Sep 23, 2023) | |||
3-113778833-C-G | Epileptic encephalopathy, infantile or early childhood, 3 • Inborn genetic diseases | Pathogenic/Likely pathogenic (Sep 27, 2024) | ||
3-113778840-G-GTAA | Likely benign (Jul 12, 2023) | |||
3-113780886-A-G | Benign (May 10, 2021) | |||
3-113781044-C-A | Likely benign (Jun 24, 2023) | |||
3-113781055-A-G | Uncertain significance (Sep 01, 2020) | |||
3-113781067-A-G | Uncertain significance (Jul 10, 2023) | |||
3-113781071-C-T | Uncertain significance (May 29, 2023) | |||
3-113781072-G-A | Likely benign (Sep 23, 2022) | |||
3-113781084-G-A | Inborn genetic diseases | Uncertain significance (Apr 19, 2023) | ||
3-113781093-G-A | Uncertain significance (Mar 07, 2023) | |||
3-113781108-C-T | Likely benign (Apr 30, 2023) | |||
3-113781112-G-A | Uncertain significance (Mar 11, 2022) | |||
3-113781124-G-A | Uncertain significance (Nov 15, 2022) | |||
3-113781135-A-G | Likely benign (Sep 01, 2022) | |||
3-113781149-T-C | Uncertain significance (Dec 22, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
ATP6V1A | protein_coding | protein_coding | ENST00000273398 | 14 | 65038 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.868 | 0.132 | 125737 | 0 | 10 | 125747 | 0.0000398 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 3.37 | 174 | 352 | 0.494 | 0.0000186 | 4039 |
Missense in Polyphen | 29 | 136.16 | 0.21298 | 1574 | ||
Synonymous | 0.214 | 112 | 115 | 0.975 | 0.00000582 | 1193 |
Loss of Function | 4.36 | 6 | 33.0 | 0.182 | 0.00000192 | 378 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000580 | 0.0000580 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.0000545 | 0.0000544 |
Finnish | 0.0000462 | 0.0000462 |
European (Non-Finnish) | 0.0000441 | 0.0000439 |
Middle Eastern | 0.0000545 | 0.0000544 |
South Asian | 0.00 | 0.00 |
Other | 0.000163 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Catalytic subunit of the peripheral V1 complex of vacuolar ATPase. V-ATPase vacuolar ATPase is responsible for acidifying a variety of intracellular compartments in eukaryotic cells. In aerobic conditions, involved in intracellular iron homeostasis, thus triggering the activity of Fe(2+) prolyl hydroxylase (PHD) enzymes, and leading to HIF1A hydroxylation and subsequent proteasomal degradation (PubMed:28296633). {ECO:0000269|PubMed:28296633}.;
- Pathway
- mTOR signaling pathway - Homo sapiens (human);Synaptic vesicle cycle - Homo sapiens (human);Phagosome - Homo sapiens (human);Epithelial cell signaling in Helicobacter pylori infection - Homo sapiens (human);Oxidative phosphorylation - Homo sapiens (human);Collecting duct acid secretion - Homo sapiens (human);Vibrio cholerae infection - Homo sapiens (human);Rheumatoid arthritis - Homo sapiens (human);Signal Transduction;Transferrin endocytosis and recycling;Ion channel transport;adenosine ribonucleotides <i>de novo</i> biosynthesis;Insulin receptor recycling;Signaling by Insulin receptor;ROS, RNS production in phagocytes;Purine metabolism;Innate Immune System;Immune System;Transport of small molecules;superpathway of purine nucleotide salvage;Iron uptake and transport;Signaling by Receptor Tyrosine Kinases;purine nucleotides <i>de novo</i> biosynthesis
(Consensus)
Recessive Scores
- pRec
- 0.237
Intolerance Scores
- loftool
- 0.221
- rvis_EVS
- -0.43
- rvis_percentile_EVS
- 25.15
Haploinsufficiency Scores
- pHI
- 0.259
- hipred
- Y
- hipred_score
- 0.698
- ghis
- 0.677
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.109
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Atp6v1a
- Phenotype
Zebrafish Information Network
- Gene name
- atp6v1aa
- Affected structure
- vH ionocyte
- Phenotype tag
- abnormal
- Phenotype quality
- flux
Gene ontology
- Biological process
- cellular iron ion homeostasis;insulin receptor signaling pathway;ATP hydrolysis coupled proton transport;regulation of macroautophagy;transferrin transport;ion transmembrane transport;cellular response to increased oxygen levels;ATP metabolic process
- Cellular component
- lysosomal membrane;vacuolar membrane;cytosol;plasma membrane;microvillus;apical plasma membrane;proton-transporting two-sector ATPase complex;proton-transporting V-type ATPase, V1 domain;myelin sheath;extracellular exosome
- Molecular function
- ATP binding;proton-transporting ATPase activity, rotational mechanism